NYSCF scientists develop new protocol to ready induced pluripotent stem cell clinical application

April 4, 2013

Reported in PLOS ONE, this cell-sorting method consistently selects the highest quality, standardized iPS cells, representing a major step forward for drug discovery and the development of cell therapies. (Science Codex)